Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Vestibular Nerve Stimulation (VeNS), Together with a Lifestyle Modification Program, Compared to a Sham Control with a Lifestyle Modification Program, As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus

NCT04595968 is registered in ClinicalTrials.gov with Neurovalens Ltd. as lead sponsor.

NCT NCT04595968
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04595968 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Vestibular Nerve Stimulation (VeNS), Together with a Lifestyle Modification Program, Compared to a Sham Control with a Lifestyle Modification Program, As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus
Lead sponsor
Neurovalens Ltd.
Phase
Not applicable
Overall status
Completed
Start date
May 21, 2021
Completion date
August 6, 2024
Enrollment
267 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes